Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease
Phase III GRADUATE studies did not meet their primary endpoints of slowing clinical decline in people with early Alzheimer’s The level of beta-amyloid removal by gantenerumab was lower than expected Topline data will be presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference Roche is committed to the Alzheimer’s community and will continue to […]
WHO releases first data on global vaccine market since COVID-19
This is the first report to capture the implications of COVID-19 for vaccine markets. Despite progress in recent decades, global market vaccine dynamics are not fully conducive to the development, supply and access for vital vaccines for public health. Vaccines prioritized by WHO are not being developed or fully invested in due to limited profit […]
Roche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs
Interim data from phase III HAVEN 7 study reinforce Hemlibra’s efficacy and safety in infants with severe haemophilia A without factor VIII inhibitors1 New and updated data support use of Polivy in diffuse large B-cell lymphoma, including its potential as a treatment option for previously untreated patients New and updated data for innovative CD20xCD3 T-cell […]
Department of Pharmaceuticals achieved the Set Targets during Special Drive on SCDPM 2.0
Department of Pharmaceuticals took up the campaign in right earnest and met set targets on pendency areas, viz. MP’s References, PMO References Inter-Departmental Memos, Inter-Ministerial Consultation References, State Government References, Public Grievances, Record Management Practices, Swachhata Campaign sites and Scrap Disposal. SCDPM 2.0 was more focused on Field Offices with respect to their daily activities […]
The European Commission and WHO extend their strategic cooperation to deliver better health for all
At the EU-WHO Strategic Dialogue on Health between the European Commissioner for Health and Food Safety Stella Kyriakides and Dr Tedros Adhanom Ghebreyesus, WHO Director-General, the European Commission (EC) and WHO agreed to enhance strategic cooperation in global health security and architecture. They will also cooperate on the implementation of major initiatives, such as the […]
ACT-Accelerator Launches Six Month Plan As World Transitions To Long-Term Covid-19 Control
Plan sets out the partnership’s key priorities and ways of working, as countries transition to managing COVID-19 as a long-term public health issue The plan’s focus is on vaccinating high-risk populations, introducing new treatments, boosting testing and securing sustained access to COVID-19 tools The Access to COVID-19 Tools Accelerator is a global collaboration to accelerate […]
Tuberculosis deaths and disease increase during the COVID-19 pandemic
An estimated 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and 1.6 million people died from TB (including 187 000 among HIV positive people), according to the World Health Organization’s 2022 Global TB report. The burden of drug-resistant TB (DR-TB) also increased by 3% between 2020 and […]
Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022
OCREVUS data will show significant benefit on slowing disease activity and progression in patients with treatment-naive early-stage relapsing-remitting multiple sclerosis (RRMS) Largest pregnancy safety data across anti-CD20 medicines for OCREVUS in multiple sclerosis (MS) Nine-year safety data for OCREVUS reinforces its favourable benefit-risk profile New research demonstrates impact of misdiagnosis and delay of starting treatment […]
Sraggering Backsliding Across Women's, Children's and Adolsent's health reveald in new UN analysis
COVID-19, conflict, climate crises exacerbate setbacks for childhood and adolescent prospects, women’s rights Berlin, 18 October 2022 – A new UN report shows that women’s and children’s health has suffered globally, as the impacts of conflict, the COVID-19 pandemic and climate change converge with devastating effects on prospects for children, young people and women. Data […]
ISPE Provides Guidance on Improving and Advancing Process Performance and Product Quality Monitoring Systems
(NORTH BETHESDA, MARYLAND, USA, 17 OCTOBER 2022) – The International Society for Pharmaceutical Engineering (ISPE) announced the release of the ISPE APQ Guide: Process Performance & Product Quality Monitoring System (PPPQMS). This Guide provides a quality management framework for assessing and advancing an organization’s PPPQMS maturity level by evaluating the following aspects: Establishing a Control […]
